Ellen M. Zane Decides Not to Stand for Election to the Board of Directors of Azenta, Inc
January 17, 2024 at 04:06 pm EST
Share
On January 10, 2024, Ellen M. Zane notified Azenta, Inc. that she has decided not to stand for election to the Board of Directors of the Company at the 2024 Annual Meeting of the Company?s Stockholders to be held on January 30, 2024, and, as a result, Ms. Zane will no longer be a nominee for re-election at the 2024 Annual Meeting and her tenure as a director will end as of the 2024 Annual Meeting. No other nominee for election at the 2024 Annual Meeting will be named in place of Ms. Zane and the size of the Board will be reduced from ten to nine members effective as of the 2024 Annual Meeting. Ms. Zane?s decision not to stand for election was not due to any disagreement with the Company.
Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Companyâs segments include Sample Management Solutions, Multiomics and B Medical Systems. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tube, and consumables and instruments). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. It provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.